Beckman Coulter Diagnostics provides clinical diagnostic products, laboratory automation systems, and testing solutions across disciplines such as chemistry, immunoassay, hematology, and microbiology. The company serves healthcare providers and laboratories by delivering accurate and timely diagnostic insights to inform clinical decisions and improve patient care.
Subscribe to see Beckman Coulter Diagnostics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Beckman Coulter Diagnostics is a medical devices, diagnostics, life sciences company headquartered in Israel. Xcout tracks 14 named people at Beckman Coulter Diagnostics, including Christian Borjesson (PRESIDENT, BECKMAN COULTER MICROBIOLOGY). Xcout recorded 1 job posting from Beckman Coulter Diagnostics in the last 90 days.
8 more named people on record for Beckman Coulter Diagnostics, with roles, board committees and tenure — see the full roster →
Xcout recorded 1 job posting from Beckman Coulter Diagnostics in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Beckman Coulter Diagnostics's hiring signals →
A few of Beckman Coulter Diagnostics's closest competitors — see the full list of competitors and alternatives →
Becton, Dickinson and Company (BD) is a global medical technology company that manufactures and provides medical devices, instrument systems, and reagents. It serves healthcare institutions, life science researchers, clinical laboratories, and the pharmaceutical industry with solutions for medication management, diagnostics, infection prevention, and surgery.
Danaher Corporation is a global life sciences and diagnostics innovator that provides technologies, tools, and services to accelerate the development of biotechnology therapies, improve diagnostic accuracy, and support life sciences research. The company serves healthcare and scientific customers worldwide to help advance medical innovations and improve human health.
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Biofire Group develops syndromic infectious disease diagnostics systems and multiplex PCR testing panels. The company serves clinical laboratories and healthcare providers by delivering rapid detection results for pathogens such as viruses, bacteria, and resistance genes.
PerkinElmer provides analytical instruments, laboratory services, software, and consumables across industries such as food safety, environmental analysis, applied markets, and biopharma. The company serves scientists and operators globally with testing and measurement solutions.
EKF Diagnostics Holdings plc, a company founded in 1990 and based in Cardiff, United Kingdom, operates as an international supplier of diagnostic solutions. The firm excels in the development, manufacturing, and distribution of a wide array of diagnostic instruments, chemical reagents, and associated products. Its extensive market reach spans across Europe, the Middle East, the Americas, Asia, Africa, and beyond. The company's product lineup addresses various critical diagnostic needs. This includes a range of hemoglobin analysis devices, such as the handheld DiaSpect Tm and the quantitative Hemo Control. EKF also provides advanced glucose and lactate analyzers like the Biosen C-Line series, alongside point-of-care solutions for diabetes management, exemplified by the Quo-Lab A1c and Quo-Test A1c. Beyond these, their offerings extend to specialized diagnostic tools: the Creamatocrit Plus for assessing lipid concentration in mothers' milk, QuPID and True20 pregnancy tests, and the STAT-Site M Beta-hydroxybutyrate analyzer. EKF further supplies a comprehensive suite of clinical chemical analyzers and reagents, designed for monitoring conditions such as ketosis, glycated albumin, glycated serum protein, and utilizing markers like Procalcitonin for bacterial infections and sepsis. Additional provisions include immunoassay kits, general chemistry analyzers like the Altair 240, micro centrifuges, the Uri-Trak 120 urine analyzer, and dedicated kits and services for COVID-19. The company also offers its manufacturing capabilities as contract solutions to third-party businesses and delivers professional laboratory services.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.